Structural Evidence for Ligand Specificity in the Binding Domain of the Human Androgen Receptor
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 53 of the 53 references it cites were found in a registry or an index.
Abstract
The crystal structures of the human androgen receptor (hAR) and human progesterone receptor ligand-binding domains in complex with the same ligand metribolone (R1881) have been determined. Both three-dimensional structures show the typical nuclear receptor fold. The change of two residues in the ligand-binding pocket between the human progesterone receptor and hAR is most likely the source for the specificity of R1881 to the hAR. The structural implications of the 14 known mutations in the ligand-binding pocket of the hAR ligand-binding domains associated with either prostate cancer or the partial or complete androgen receptor insensitivity syndrome were analyzed. The effects of most of these mutants could be explained on the basis of the crystal structure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The LBD and DBD X-ray crystal structures of AR have been solved separately (Matias et al., 2000; Sack et al., 2001; Shaffer et al., 2004).”
From Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes (2020) · cites this paper as Matias et al., 2000
Citations
Cites
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Kabsch, W., & Sander, C. (1983) · Biopolymers · doi:10.1002/bip.360221211 · Cited by 15,320
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, P. J. (1991) · Journal of Applied Crystallography · doi:10.1107/s0021889891004399 · Cited by 14,085
Jones, T. A., Zou, J. Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,648
The protein data bank: A computer-based archival file for macromolecular structures
Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer, E. F., Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T., & Tasumi, M. (1977) · Journal of Molecular Biology · doi:10.1016/s0022-2836(77)80200-3 · Cited by 8,578
AMoRe: an automated package for molecular replacement
Navaza, J. (1994) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767393007597 · Cited by 4,953
Research works printed but not linked: 8
- Otwinowski, 1997, 276, 307
- Lamzin, 1997, 277, 269
- Kleywegt, 1995, Joint CCP4 and ESF-EACMB Newsletter on Protein Crystallography, 31, 45
- Bellis, 1992, Mol. Endocrinol., 6, 1909
- Pinsky, 1992, Clin. Invest. Med., 15, 456
- Lumbroso, 1996, J. Clin. Endocrinol. & Metab., 81, 1984
- Jakubicza, 1992, Hum. Genet., 90, 311
- Nakao, 1992, J. Clin. Endocrinol. & Metab., 74, 1152
Cited by
Items 101–200 of 696
Bohl, C. E., Wu, Z. R., Miller, D. D., Bell, C. E., & Dalton, J. T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611711200 · Cited by 133
Different Clinical Presentations and Management in Complete Androgen Insensitivity Syndrome (CAIS)
Lanciotti, L., Cofini, M., Leonardi, A., Bertozzi, M., Penta, L., & Esposito, S. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16071268 · Cited by 133
Thompson, J. (2001) · Molecular Endocrinology · doi:10.1210/me.15.6.923 · Cited by 126
Key Structural Features of Nonsteroidal Ligands for Binding and Activation of the Androgen Receptor
Yin, D., He, Y., Perera, M. A., Hong, S., Marhefka, C. A., Stourman, N. V., Kirkovsky, L. I., Miller, D. D., & Dalton, J. T. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.1.211 · Cited by 124
Han, G., Foster, B. A., Mistry, S., Buchanan, G., Harris, J. M., Tilley, W. D., & Greenberg, N. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008207200 · Cited by 123
Minireview: Not Picking Pockets: Nuclear Receptor Alternate-Site Modulators (NRAMs)
Moore, T. W., Mayne, C. G., & Katzenellenbogen, J. A. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0362 · Cited by 123
Buchanan, G. (2001) · Molecular Endocrinology · doi:10.1210/me.15.1.46 · Cited by 122
Androgen receptor gene mutation, rearrangement, polymorphism.
Eisermann, K., Wang, D., Jing, Y., Pascal, L. E., & Wang, Z. (2013) · PubMed Central · doi:10.3978/j.issn.2223-4683.2013.09.15 · Cited by 126
Novel Non-Steroidal/Non-Anilide Type Androgen Antagonists with an Isoxazolone Moiety
Ishioka, T., Kubo, A., Koiso, Y., Nagasawa, K., Itai, A., & Hashimoto, Y. (2002) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(01)00421-7 · Cited by 120
Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol
Suino-Powell, K. M., Xu, Y., Zhang, C., Tao, Y., Tolbert, W. D., Simons, S. S., & Xu, H. E. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01541-07 · Cited by 119
Song, L.-N., Coghlan, M., & Gelmann, E. P. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0189 · Cited by 116
Dehm, S. M., & Tindall, D. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605002200 · Cited by 113
Edman, K., Hosseini, A., Bjursell, M. K., Aagaard, A., Wissler, L., Gunnarsson, A., Kaminski, T., Köhler, C., Bäckström, S., Jensen, T. J., et al. (2015) · Structure · doi:10.1016/j.str.2015.09.012 · Cited by 111
Molecular biology of androgen insensitivity
Jääskeläinen, J. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.006 · Cited by 110
Interdomain interactions in the mineralocorticoid receptor
Rogerson, F. M., & Fuller, P. J. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00413-6 · Cited by 109
Mechanism of Androgen Receptor Antagonism by Bicalutamide in the Treatment of Prostate Cancer
Osguthorpe, D. J., & Hagler, A. T. (2011) · Biochemistry · doi:10.1021/bi102059z · Cited by 108
Identification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen Receptor
Zhou, X. E., Suino-Powell, K. M., Li, J., He, Y., MacKeigan, J. P., Melcher, K., Yong, E.-L., & Xu, H. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.085779 · Cited by 106
The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons
Poletti, A. (2004) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2004.03.001 · Cited by 105
The Deubiquitinating Enzyme USP26 Is a Regulator of Androgen Receptor Signaling
Dirac, A. M. G., & Bernards, R. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0424 · Cited by 102
Marhefka, C. A., Moore, B. M., II, Bishop, T. C., Kirkovsky, L. I., Mukherjee, A., Dalton, J. T., & Miller, D. D. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0005353 · Cited by 102
Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs
Bisson, W. H., Cheltsov, A. V., Bruey-Sédano, N., Lin, B., Chen, J., Goldberger, N. E., May, L. T., Christopoulos, A., Dalton, J. T., Sexton, P. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609752104 · Cited by 101
Structure–function relationships in the mineralocorticoid receptor
Pippal, J. B., & Fuller, P. J. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0093 · Cited by 101
Switching and withdrawing hormonal agents for castration-resistant prostate cancer
Lorente, D., Mateo, J., Zafeiriou, Z., Smith, A. D., Sandhu, S. K., Ferraldeschi, R., & Bono, J. S. D. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2014.345 · Cited by 99
The fate of the duplicated androgen receptor in fishes: a late neofunctionalization event?
Douard, V., Brunet, F., Boussau, B., Ahrens-Fath, I., Vlaeminck-Guillem, V., Haendler, B., Laudet, V., & Guiguen, Y. (2008) · BMC Evolutionary Biology · doi:10.1186/1471-2148-8-336 · Cited by 95
Lavery, D. N., & McEwan, I. J. (2008) · Biochemistry · doi:10.1021/bi702221e · Cited by 93
Molecular pathology of the androgen receptor in male (in)fertility
Gottlieb, B., Lombroso, R., Beitel, L. K., & Trifiro, M. A. (2005) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60802-4 · Cited by 93
Electrostatic Modulation in Steroid Receptor Recruitment of LXXLL and FXXLF Motifs
He, B., & Wilson, E. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.2135-2150.2003 · Cited by 92
Duff, J., & McEwan, I. J. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0231 · Cited by 92
Structural analyses of sex hormone-binding globulin reveal novel ligands and function
Avvakumov, G. V., Cherkasov, A., Muller, Y. A., & Hammond, G. L. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.005 · Cited by 91
A magic drug target: Androgen receptor
Li, D., Zhou, W., Pang, J., Tang, Q., Zhong, B., Shen, C., Li, X., & Hou, T. (2018) · Medicinal Research Reviews · doi:10.1002/med.21558 · Cited by 91
Madauss, K. P., Deng, S.-J., Austin, R. J. H., Lambert, M. H., McLay, I., Pritchard, J., Short, S. A., Stewart, E. L., Uings, I. J., & Williams, S. P. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030640n · Cited by 90
Structure–function relationships of vitamin D including ligand recognition by the vitamin D receptor
Yamada, S., Shimizu, M., & Yamamoto, K. (2002) · Medicinal Research Reviews · doi:10.1002/med.10023 · Cited by 90
Wang, J., Li, Z., & Yang, W.-X. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.838858 · Cited by 89
Hannema, S. E., Scott, I. S., Hodapp, J., Martin, H., Coleman, N., Schwabe, J. W. R., & Hughes, I. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0709 · Cited by 89
AR function in promoting metastatic prostate cancer
Augello, M. A., Den, R. B., & Knudsen, K. E. (2014) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9471-3 · Cited by 88
Krishnan, A. V., Zhao, X.-Y., Swami, S., Brive, L., Peehl, D. M., Ely, K. R., & Feldman, D. (2002) · Endocrinology · doi:10.1210/en.143.5.1889 · Cited by 87
Matias, P. M., Carrondo, M. A., Coelho, R., Thomaz, M., Zhao, X.-Y., Wegg, A., Crusius, K., Egner, U., & Donner, P. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm011072j · Cited by 86
Self-citationIntrinsic disorder in the androgen receptor: identification, characterisation and drugability
McEwan, I. J. (2011) · Molecular BioSystems · doi:10.1039/c1mb05249g · Cited by 86
Hsu, C.-L., Chen, Y.-L., Yeh, S., Ting, H.-J., Hu, Y.-C., Lin, H., Wang, X., & Chang, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211908200 · Cited by 85
Dehm, S. M., Regan, K. M., Schmidt, L. J., & Tindall, D. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1267 · Cited by 84
Specificity of cyclin D1 for androgen receptor regulation.
Petre, C. E., Cook, S. L., Burd, C. J., Marshall, T. W., Wetherill, Y. B., & Knudsen, K. E. (2003) · PubMed · Cited by 84
Androgen receptor–cofactor interactions as targets for new drug discovery
Chang, C., & McDonnell, D. P. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.002 · Cited by 84
Molecular Mechanisms of Androgen Action – A Historical Perspective
Brinkmann, A. O. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-243-4_1 · Cited by 83
Blankvoort, B. M. G., de Groene, E. M., Kreikamp, A. P., Witkamp, R. F., Rodenburg, R. J., & Aarts, J. M. M. J. G. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5352 · Cited by 83
Structure and Function of the Glucocorticoid Receptor Ligand Binding Domain
Bledsoe, R. K., Stewart, E. L., & Pearce, K. H. (2004) · Vitamins and hormones · doi:10.1016/s0083-6729(04)68002-2 · Cited by 85
The Androgen Receptor Acetylation Site Regulates cAMP and AKT but Not ERK-induced Activity
Fu, M., Rao, M., Wu, K., Wang, C., Zhang, X., Hessien, M., Yeung, Y.-G., Gioeli, D., Weber, M. J., & Pestell, R. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313466200 · Cited by 82
HYYTINEN, E.-R., Haapala, K., Thompson, J. S., Lappalainen, I., Roiha, M., Rantala, I. S., Helin, H. J., Jänne, O. A., Vihinen, M., Palvimo, J. J., et al. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000038924.67707.75 · Cited by 82
Tamura, H., Ishimoto, Y., Fujikawa, T., Aoyama, H., Yoshikawa, H., & Akamatsu, M. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.06.064 · Cited by 82
Bohl, C. E., Chang, C. K., Mohler, M. L., Chen, J., Miller, D. D., Swaan, P. W., & Dalton, J. T. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0499007 · Cited by 81
Gasmi, J., & Sanderson, J. T. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf103306k · Cited by 80
Recent developments in antiandrogens and selective androgen receptor modulators
Haendler, B., & Cleve, A. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.002 · Cited by 80
Evaluation of Ligand-Dependent Changes in AR Structure Using Peptide Probes
Chang, C.-Y. (2002) · Molecular Endocrinology · doi:10.1210/me.16.4.647 · Cited by 80
Tan, J.-A., Hall, S. H., Hamil, K. G., Grossman, G., Petrusz, P., & French, F. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109217200 · Cited by 80
Brooke, G. N., Parker, M. G., & Bevan, C. L. (2008) · Oncogene · doi:10.1038/sj.onc.1210955 · Cited by 79
Kumar, R., & Litwack, G. (2009) · Steroids · doi:10.1016/j.steroids.2009.07.012 · Cited by 79
Eftekharzadeh, B., Banduseela, V. C., Chiesa, G., Martínez-Cristóbal, P., Rauch, J. N., Nath, S. R., Schwarz, D. M. C., Shao, H., Marin-Argany, M., Di Sanza, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11594-y · Cited by 76
Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor
Sadar, M. D. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1732920 · Cited by 76
Zhang, Z., Olland, A. M., Zhu, Y., Cohen, J., Berrodin, T., Chippari, S., Appavu, C., Li, S., Wilhem, J., Chopra, R., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504144200 · Cited by 76
The genetics of male undermasculinization
Ahmed, S. F., & Hughes, I. A. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01430.x · Cited by 76
He, B., Gampe, R. T., Hnat, A. T., Faggart, J. L., Minges, J. T., French, F. S., & Wilson, E. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m511738200 · Cited by 76
Antiandrogens: selective androgen receptor modulators
Berrevoets, C., Umar, A., & Brinkmann, A. O. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00373-8 · Cited by 76
Androgen Receptor: A Complex Therapeutic Target for Breast Cancer
Narayanan, R., & Dalton, J. T. (2016) · Cancers · doi:10.3390/cancers8120108 · Cited by 76
Wang, Q., Lu, J., & Yong, E. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009916200 · Cited by 75
Structural Basis for HNF-4α Activation by Ligand and Coactivator Binding
Duda, K., Chi, Y.-I., & Shoelson, S. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400864200 · Cited by 75
Huxley, M., Sánchez-Cano, C., Browning, M. J., Navarro‐Ranninger, C., Quiroga, A. G., Rodger, A., & Hannon, M. J. (2010) · Dalton Transactions · doi:10.1039/c0dt00838a · Cited by 74
Complexities of androgen action
McPhaul, M. J., & Young, M. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.117429 · Cited by 73
Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgen
Ariazi, E. A., Leitão, A., Oprea, T. I., Chen, B., Louis, T., Bertucci, A. M., Sharma, C. G. N., Gill, S. D., Kim, H. R., Shupp, H. A., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0312 · Cited by 72
Hong, H., Fang, H., Xie, Q., Perkins, R., Sheehan, D. M., & Tong, W. (2003) · SAR and QSAR in environmental research · doi:10.1080/10629360310001623962 · Cited by 71
Naftalin, R. J., Afzal, I., Cunningham, P., Halai, M. M., Ross, C. L., Salleh, N., & Milligan, S. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705460 · Cited by 70
Allosteric Conversation in the Androgen Receptor Ligand-Binding Domain Surfaces
Grosdidier, S., Carbó, L. R., Buzón, V., Brooke, G., Nguyen, P., Baxter, J. D., Bevan, C., Webb, P., Estébanez-Perpiñá, E., & Fernández-Recio, J. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1281 · Cited by 69
AR-V7 and prostate cancer: The watershed for treatment selection?
Ciccarese, C., Santoni, M., Brunelli, M., Buti, S., Modena, A., Nabissi, M., Artibani, W., Martignoni, G., Montironi, R., Tortora, G., et al. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.12.003 · Cited by 68
Tunable recognition of the steroid α-face by adjacent π-electron density
Friščić, T., Lancaster, R. W., Fábián, L., & Karamertzanis, P. G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915142107 · Cited by 68
The E3 ubiquitin ligase CHIP binds the androgen receptor in a phosphorylation-dependent manner
Rees, I., Lee, S., Kim, H., & Tsai, F. (2006) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2006.03.013 · Cited by 67
Beyond the Ligand-Binding Pocket: Targeting Alternate Sites in Nuclear Receptors
Caboni, L., & Lloyd, D. G. (2012) · Medicinal Research Reviews · doi:10.1002/med.21275 · Cited by 67
Cantin, L., Faucher, F., Couture, J., de Jesus-Tran, K. P., Legrand, P., Ciobanu, L. C., Fréchette, Y., Labrecque, R., Singh, S. M., Labrie, F., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705524200 · Cited by 67
Hodgson, M. C., Shen, H. C., Hollenberg, A. N., & Balk, S. P. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0461 · Cited by 67
Ghali, S. A., Gottlieb, B., Lumbroso, R., Beitel, L. K., Elhaji, Y. A., Wu, J. H., Pinsky, L., & Trifiro, M. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021324 · Cited by 67
van de Wijngaart, D. J., Molier, M., Lusher, S. J., Hersmus, R., Jenster, G., Trapman, J., & Dubbink, H. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.039958 · Cited by 65
46,XY disorders of sex development – the undermasculinised male with disorders of androgen action
Werner, R., Grötsch, H., & Hiort, O. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.11.002 · Cited by 65
Jääskeläinen, J., Deeb, A., Schwabe, J. W. R., Mongan, N. P., Martin, H., & Hughes, I. A. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01885 · Cited by 65
Androgen receptor and soy isoflavones in prostate cancer (Review)
Sivoňov�, M., Kapl�n, P., Tatarkov�, Z., Lichardusov�, L., Dusenka, R., & Jurečekov�, J. (2018) · Molecular and Clinical Oncology · doi:10.3892/mco.2018.1792 · Cited by 64
Zaveri, N. T., & Murphy, B. J. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00063-8 · Cited by 64
Evidence for DNA-Binding Domain–Ligand-Binding Domain Communications in the Androgen Receptor
Helsen, C., Dubois, V., Verfaillie, A., Young, J., Trekels, M., Vancraenenbroeck, R., De Maeyer, M., & Claessens, F. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00151-12 · Cited by 63
Chen, L., Zhang, Z., Han, Q., Maity, B. K., Rodrigues, L., Zboril, E. K., Adhikari, R., Ko, S. H., Li, X., Yoshida, S. R., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.08.027 · Cited by 63
Quigley, C. A., Tan, J.-A., He, B., Zhou, Z.-X., Mébarki, F., Morel, Y., Forest, M. G., Chatelain, P., Ritzén, E. M., French, F. S., et al. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.08.007 · Cited by 63
Neurotoxic effects of androgens in spinal and bulbar muscular atrophy
Parodi, S., & Pennuto, M. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.06.003 · Cited by 63
Interaction of organophosphate pesticides and related compounds with the androgen receptor.
Tamura, H., Yoshikawa, H., Gaido, K. W., Ross, S. M., DeLisle, R. K., Welsh, W. J., & Richard, A. M. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.5671 · Cited by 63
Moore, N. L. T., Buchanan, G., Harris, J. M., Selth, L. A., Bianco‐Miotto, T., Hanson, A. R., Birrell, S. N., Butler, L. M., Hickey, T. E., & Tilley, W. D. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0065 · Cited by 61
Ozers, M. S., Marks, B. D., Gowda, K., Kupcho, K. R., Ervin, K. M., De Rosier, T., Qadir, N., Eliason, H. C., Riddle, S. M., & Shekhani, M. S. (2007) · Biochemistry · doi:10.1021/bi061321b · Cited by 59
Baker, M. E., Chandsawangbhuwana, C., & Ollikainen, N. (2007) · BMC Evolutionary Biology · doi:10.1186/1471-2148-7-24 · Cited by 59
Hu, R., Denmeade, S. R., & Luo, J. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.10.49 · Cited by 61
Leva, F. S. D., Festa, C., D’Amore, C., Marino, S. D., Renga, B., D’Auria, M. V., Novellino, E., Limongelli, V., Zampella, A., & Fiorucci, S. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400419e · Cited by 59
Neofunctionalization of Androgen Receptor by Gain-of-Function Mutations in Teleost Fish Lineage
Ogino, Y., Kuraku, S., Ishibashi, H., Miyakawa, H., Sumiya, E., Miyagawa, S., Matsubara, H., Yamada, G., Baker, M. E., & Iguchi, T. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msv218 · Cited by 59
Kumar, R., Moure, C. M., Khan, S. H., Callaway, C., Grimm, S. L., Goswami, D., Griffin, P. R., & Edwards, D. P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.491787 · Cited by 59
Duan, M., Liu, N., Zhou, W., Li, D., Yang, M., & Hou, T. (2016) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.6b00424 · Cited by 58
A new class of androgen receptor antagonists bearing carborane in place of a steroidal skeleton
Fujii, S., Hashimoto, Y., Suzuki, T., Ohta, S., & Endo, Y. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.09.091 · Cited by 58
X-Ray Crystallography in Drug Discovery
Carvalho, A. L., Trincão, J., & Romão, M. J. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-244-5_3 · Cited by 57
Holterhus, P., Piefke, S., & Hiort, O. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00220-0 · Cited by 57
Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on
Estébanez‐Perpiñá, E., Bevan, C. L., & McEwan, I. J. (2021) · Cancers · doi:10.3390/cancers13030509 · Cited by 57
Structure–activity relationships of synthetic progestins in a yeast-based in vitro androgen bioassay
McRobb, L. S., Handelsman, D. J., Kazlauskas, R., Wilkinson, S. M., McLeod, M. D., & Heather, A. K. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.10.008 · Cited by 56
Metadata
- Authors
- Matias, P. M., Donner, P., Coelho, R., Thomaz, M., Peixoto, C., Macedo, S., Otto, N., Joschko, S., Scholz, P., Wegg, A., Bäsler, S., Schäfer, M., Egner, U., & Carrondo, M. A.
- Affiliations
- Universidade Nova de Lisboa (PT)
- Instituto de Biologia Experimental e Tecnológica (PT)
- Corresponding author
- Carrondo, Maria Arménia
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-08
- Volume
- 275
- Issue
- 34
- Pages
- 26164-26171
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2151922331
- Cited by
- 608
- References
- 53
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 14 · 2023: 20 · 2022: 17 · 2021: 12 · 2020: 18 · 2019: 11 · 2018: 13 · 2017: 14 · 2016: 16 · 2015: 23 · 2014: 12 · 2013: 22 · 2012: 17
- FWCI
- 37.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7373 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- androgen receptor, ligand-binding domain, ligand specificity, progesterone receptor, binding pocket, point mutations, prostate cancer, crystal structure
- MeSH terms
- Amino Acid Sequence, Binding Sites, Humans, Ligands, Male, Models, Chemical, Models, Molecular, Molecular Conformation, Molecular Sequence Data, Prostatic Neoplasms, Protein Conformation, Receptors, Androgen, Metribolone, Mutagenesis, Site-Directed, Crystallography, X-Ray, Amino Acid Substitution, Testosterone Congeners
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.